Alzheimer’s Research UK launches three Drug Discovery Institutes

Alzheimer’s Research UK, the world’s largest dedicated dementia research charity, has announced a £30m Drug Discovery Alliance, launching three flagship Drug Discovery Institutes at the Universities of Cambridge, Oxford and UCL (University College London). The Drug Discovery Institutes will see 90 new research scientists employed in state-of-the-art facilities to fast-track the development of new treatments for Alzheimer’s disease and other dementias.